Mustang Bio is a New York-based biopharmaceutical company that discovers and develops cell and gene therapies to treat hematologic cancer, solid tumors and genetic diseases.
Business Model:
Revenue: $2.4M
Employees: 51-200
Address: 377 Plantation Street
City: Worcester
State: NY
Zip: 01605
Country: US
Mustang Bio is a New York-based biopharmaceutical company that discovers and develops cell and gene therapies to treat hematologic cancer, solid tumors and genetic diseases.
Contact Phone:
+17816524500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/1/2017
Ticker Symbol:
MBIO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2022 | Post-IPO Debt | 1 | $75M |
Runway Growth Capital Runway Growth Capital |
8/2017 | Post-IPO Equity | $94.5M | 10/2017 | Grant | 1 | $12.8M |
California Institute of Regenerative Medicine (CIRM) California Institute of Regenerative Medicine (CIRM) California Institute of Regenerative Medicine (CIRM) California Institute of Regenerative Medicine (CIRM) |
4/2019 | Post-IPO Debt | 1 | $20M |
Horizon Technology Finance Horizon Technology Finance Horizon Technology Finance Horizon Technology Finance |
3/2019 | Post-IPO Debt | $20M |
Horizon Technology Finance |
5/2019 | Post-IPO Debt | $32M | 6/2020 | Post-IPO Equity | $40M | 10/2021 | Grant | $2M |
National Cancer Institute |
11/2021 | Grant | 1 | $2M |
National Institutes of Health National Institutes of Health |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|